Population pharmacokinetics of abacavir in pregnant women

12Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

For the first time, a population approach was used to describe abacavir (ABC) pharmacokinetics in HIV-infected pregnant and nonpregnant women. A total of 266 samples from 150 women were obtained. No covariate effect (from age, body weight, pregnancy, or gestational age) on ABC pharmacokinetics was found. Thus, it seems unnecessary to adapt the ABC dosing regimen during pregnancy.Copyright

Cite

CITATION STYLE

APA

Fauchet, F., Treluyer, J. M., Préta, L. H., Valade, E., Pannier, E., Urien, S., & Hirt, D. (2014). Population pharmacokinetics of abacavir in pregnant women. Antimicrobial Agents and Chemotherapy, 58(10), 6287–6289. https://doi.org/10.1128/AAC.03469-14

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free